The National Research Council of Canada said Tuesday it will work with a Chinese company to try to develop its potential vaccine for COVID-19 more quickly.
The National Research Council of Canada said Tuesday it will work with a Chinese company to try to develop its potential vaccine for COVID-19 more quickly.
The Chinese company, CanSino Biologics, is already conducting human clinical trials for its vaccine.
Federal governments the world over have said vaccines are urgently needed to allow mass gatherings to resume. But that’s only if clinical trials in thousands of human volunteers show safety and efficacy before shots go into the arms of vast swaths of the general public.
As of April, five vaccine candidates have moved into clinical development in early stage human trials, including CanSino‘s, called Ad5-nCoV.
The collaboration announced on Tuesday will allow Canada’s publicly funded research council to try to scale up the technology needed to produce enough of the candidate vaccine to protect Canadians.
Matthew Herder, director of the Health Law Institute at Dalhousie University’s law sch